Manufacturing Defects

The identification of residual solvent OOS during transdermal patch manufacturing typically surfaces through various symptoms or signals, notably:Click to read the full article.

Identifying symptoms of dose delivery inconsistency is the first step in managing manufacturing defects. Common signals include:Click to read the full article.

Identifying symptoms of dose delivery inconsistency is the first critical step in a deviation investigation. These symptoms may manifest through various channels:Click to read the full article.

Recognizing the signs of patch curling is critical in initiating an effective investigation. Symptoms may manifest in various ways, and understanding these signals can help pinpoint the root cause.Click to…

Identifying the symptoms of dose delivery inconsistencies is the first step in any effective investigation. These symptoms may include:Click to read the full article.

The initial signals indicating edge lifting during transdermal patch manufacturing can manifest in various ways. Symptoms may include:Click to read the full article.

Symptoms of dose delivery inconsistency following an adhesive change may manifest in various ways, both on the manufacturing floor and in lab testing. It is essential for personnel to closely…

Symptoms of backing delamination can often be first detected during routine quality control checks, stability studies, or by end-user complaints. It's essential to accurately document and categorize these signals to…

Recognizing the signs of adhesion failure is crucial in a timely investigation. Common symptoms on the production floor or in the laboratory include:Click to read the full article.

The first step in any deviation investigation is to identify and document the symptoms indicating the issue. Symptoms of patch curling after adhesive change may include:Click to read the full…

The detection of residual solvent OOS after lamination typically initiates from various signals encountered during the quality control (QC) phase. These signals could include:Click to read the full article.

Edge lifting is characterized by the detachment of the edges of a transdermal patch from its substrate, potentially leading to compromised product efficacy due to reduced adhesion. This defect can…